JPWO2019241426A5 - - Google Patents

Info

Publication number

JPWO2019241426A5

JPWO2019241426A5 JP2020568398A JP2020568398A JPWO2019241426A5 JP WO2019241426 A5 JPWO2019241426 A5 JP WO2019241426A5 JP 2020568398 A JP2020568398 A JP 2020568398A JP 2020568398 A JP2020568398 A JP 2020568398A JP WO2019241426 A5 JPWO2019241426 A5 JP WO2019241426A5

Authority

JP

Japan

Prior art keywords

seq

nucleic acid

acid sequence

amino acid

domain

Prior art date

2022-06-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 305
• 210000004027 cell Anatomy 0.000 claims description 285
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 282
• 230000027455 binding Effects 0.000 claims description 272
• 238000009739 binding Methods 0.000 claims description 272
• 150000007523 nucleic acids Chemical class 0.000 claims description 239
• 102100035360 Cerebellar degeneration-related antigen 1 Human genes 0.000 claims description 144
• 230000011664 signaling Effects 0.000 claims description 131
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 129
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 119
• 230000004068 intracellular signaling Effects 0.000 claims description 111
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 100
• 102000039446 nucleic acids Human genes 0.000 claims description 99
• 108020004707 nucleic acids Proteins 0.000 claims description 99
• 206010028980 Neoplasm Diseases 0.000 claims description 96
• 229920001184 polypeptide Polymers 0.000 claims description 91
• 108090000623 proteins and genes Proteins 0.000 claims description 67
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 56
• 201000011510 cancer Diseases 0.000 claims description 54
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 52
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 52
• 108010047041 Complementarity Determining Regions Proteins 0.000 claims description 50
• 239000013598 vector Substances 0.000 claims description 50
• 230000014509 gene expression Effects 0.000 claims description 49
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 47
• 108091008874 T cell receptors Proteins 0.000 claims description 45
• 102000004169 proteins and genes Human genes 0.000 claims description 45
• 239000012634 fragment Substances 0.000 claims description 43
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 42
• 238000000034 method Methods 0.000 claims description 36
• -1 ICOS (CD278) Proteins 0.000 claims description 33
• 150000001413 amino acids Chemical class 0.000 claims description 33
• 201000010099 disease Diseases 0.000 claims description 31
• 238000011282 treatment Methods 0.000 claims description 31
• 210000000822 natural killer cell Anatomy 0.000 claims description 28
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 27
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 27
• 230000000139 costimulatory effect Effects 0.000 claims description 27
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 claims description 25
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 claims description 24
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims description 22
• 239000003446 ligand Substances 0.000 claims description 22
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 21
• 102100029215 Signaling lymphocytic activation molecule Human genes 0.000 claims description 21
• 101000946843 Homo sapiens T-cell surface glycoprotein CD8 alpha chain Proteins 0.000 claims description 19
• 102100034922 T-cell surface glycoprotein CD8 alpha chain Human genes 0.000 claims description 19
• 102100027207 CD27 antigen Human genes 0.000 claims description 18
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 claims description 18
• 102100022339 Integrin alpha-L Human genes 0.000 claims description 17
• 239000003814 drug Substances 0.000 claims description 17
• 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims description 16
• 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims description 16
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 16
• 108020004414 DNA Proteins 0.000 claims description 16
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 16
• 101000633786 Homo sapiens SLAM family member 6 Proteins 0.000 claims description 16
• 102100029197 SLAM family member 6 Human genes 0.000 claims description 16
• 108010074687 Signaling Lymphocytic Activation Molecule Family Member 1 Proteins 0.000 claims description 16
• 230000004913 activation Effects 0.000 claims description 16
• 208000035475 disorder Diseases 0.000 claims description 16
• 101000935040 Homo sapiens Integrin beta-2 Proteins 0.000 claims description 15
• 102100032816 Integrin alpha-6 Human genes 0.000 claims description 15
• 102100025390 Integrin beta-2 Human genes 0.000 claims description 15
• 101000994375 Homo sapiens Integrin alpha-4 Proteins 0.000 claims description 14
• 102100032818 Integrin alpha-4 Human genes 0.000 claims description 14
• 238000000338 in vitro Methods 0.000 claims description 14
• 238000004519 manufacturing process Methods 0.000 claims description 13
• 102100024263 CD160 antigen Human genes 0.000 claims description 12
• 101000761938 Homo sapiens CD160 antigen Proteins 0.000 claims description 12
• 101000648507 Homo sapiens Tumor necrosis factor receptor superfamily member 14 Proteins 0.000 claims description 12
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 claims description 12
• 208000034578 Multiple myelomas Diseases 0.000 claims description 12
• 206010053869 POEMS syndrome Diseases 0.000 claims description 12
• 208000007452 Plasmacytoma Diseases 0.000 claims description 12
• 229960002930 sirolimus Drugs 0.000 claims description 12
• 229940124597 therapeutic agent Drugs 0.000 claims description 12
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims description 11
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims description 11
• 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 11
• 102100026878 Interleukin-2 receptor subunit alpha Human genes 0.000 claims description 11
• 206010025323 Lymphomas Diseases 0.000 claims description 11
• 229940124302 mTOR inhibitor Drugs 0.000 claims description 11
• 239000003628 mammalian target of rapamycin inhibitor Substances 0.000 claims description 11
• QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 11
• 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 10
• 102100038077 CD226 antigen Human genes 0.000 claims description 10
• 102100038078 CD276 antigen Human genes 0.000 claims description 10
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 10
• 101000884298 Homo sapiens CD226 antigen Proteins 0.000 claims description 10
• 101001078158 Homo sapiens Integrin alpha-1 Proteins 0.000 claims description 10
• 101000994365 Homo sapiens Integrin alpha-6 Proteins 0.000 claims description 10
• 101001035237 Homo sapiens Integrin alpha-D Proteins 0.000 claims description 10
• 101001046687 Homo sapiens Integrin alpha-E Proteins 0.000 claims description 10
• 101000935043 Homo sapiens Integrin beta-1 Proteins 0.000 claims description 10
• 101000971538 Homo sapiens Killer cell lectin-like receptor subfamily F member 1 Proteins 0.000 claims description 10
• 101000633780 Homo sapiens Signaling lymphocytic activation molecule Proteins 0.000 claims description 10
• 102100025323 Integrin alpha-1 Human genes 0.000 claims description 10
• 102100039904 Integrin alpha-D Human genes 0.000 claims description 10
• 102100022341 Integrin alpha-E Human genes 0.000 claims description 10
• 102100022338 Integrin alpha-M Human genes 0.000 claims description 10
• 102100022297 Integrin alpha-X Human genes 0.000 claims description 10
• 102100025304 Integrin beta-1 Human genes 0.000 claims description 10
• 102100021458 Killer cell lectin-like receptor subfamily F member 1 Human genes 0.000 claims description 10
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims description 10
• 201000003793 Myelodysplastic syndrome Diseases 0.000 claims description 10
• 102100027744 Semaphorin-4D Human genes 0.000 claims description 10
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 10
• ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 10
• 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 9
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 9
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 claims description 9
• 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 claims description 9
• 206010060862 Prostate cancer Diseases 0.000 claims description 9
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 9
• 102000014128 RANK Ligand Human genes 0.000 claims description 9
• 108010025832 RANK Ligand Proteins 0.000 claims description 9
• 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 9
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 9
• 230000001939 inductive effect Effects 0.000 claims description 9
• 201000000050 myeloid neoplasm Diseases 0.000 claims description 9
• 239000013612 plasmid Substances 0.000 claims description 9
• 210000004180 plasmocyte Anatomy 0.000 claims description 9
• 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 claims description 8
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 claims description 8
• 102100029198 SLAM family member 7 Human genes 0.000 claims description 8
• 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims description 8
• 239000003112 inhibitor Substances 0.000 claims description 8
• 230000002062 proliferating effect Effects 0.000 claims description 8
• 208000010721 smoldering plasma cell myeloma Diseases 0.000 claims description 8
• 101001043809 Homo sapiens Interleukin-7 receptor subunit alpha Proteins 0.000 claims description 7
• 101000809875 Homo sapiens TYRO protein tyrosine kinase-binding protein Proteins 0.000 claims description 7
• 102100021593 Interleukin-7 receptor subunit alpha Human genes 0.000 claims description 7
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 7
• 102100038717 TYRO protein tyrosine kinase-binding protein Human genes 0.000 claims description 7
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 7
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 claims description 7
• 201000000564 macroglobulinemia Diseases 0.000 claims description 7
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 6
• 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 6
• 101150013553 CD40 gene Proteins 0.000 claims description 6
• 229940045513 CTLA4 antagonist Drugs 0.000 claims description 6
• 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims description 6
• 102100029360 Hematopoietic cell signal transducer Human genes 0.000 claims description 6
• 101000990188 Homo sapiens Hematopoietic cell signal transducer Proteins 0.000 claims description 6
• 101000633778 Homo sapiens SLAM family member 5 Proteins 0.000 claims description 6
• 101000633782 Homo sapiens SLAM family member 8 Proteins 0.000 claims description 6
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 6
• 102000003812 Interleukin-15 Human genes 0.000 claims description 6
• 108090000172 Interleukin-15 Proteins 0.000 claims description 6
• 108010053727 Interleukin-15 Receptor alpha Subunit Proteins 0.000 claims description 6
• 241000713666 Lentivirus Species 0.000 claims description 6
• 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims description 6
• 102100029216 SLAM family member 5 Human genes 0.000 claims description 6
• 102100029214 SLAM family member 8 Human genes 0.000 claims description 6
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 claims description 6
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 6
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 6
• 201000003444 follicular lymphoma Diseases 0.000 claims description 6
• 102000003298 tumor necrosis factor receptor Human genes 0.000 claims description 6
• 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims description 5
• 108010056102 CD100 antigen Proteins 0.000 claims description 5
• 108010017009 CD11b Antigen Proteins 0.000 claims description 5
• 102100032937 CD40 ligand Human genes 0.000 claims description 5
• 102100027217 CD82 antigen Human genes 0.000 claims description 5
• 101710139831 CD82 antigen Proteins 0.000 claims description 5
• 102100035793 CD83 antigen Human genes 0.000 claims description 5
• 102100025466 Carcinoembryonic antigen-related cell adhesion molecule 3 Human genes 0.000 claims description 5
• 102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 claims description 5
• 102100025137 Early activation antigen CD69 Human genes 0.000 claims description 5
• HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 claims description 5
• 102100022086 GRB2-related adapter protein 2 Human genes 0.000 claims description 5
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 claims description 5
• 101000914337 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 3 Proteins 0.000 claims description 5
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 claims description 5
• 101001046683 Homo sapiens Integrin alpha-L Proteins 0.000 claims description 5
• 101001046686 Homo sapiens Integrin alpha-M Proteins 0.000 claims description 5
• 101001046668 Homo sapiens Integrin alpha-X Proteins 0.000 claims description 5
• 101001015037 Homo sapiens Integrin beta-7 Proteins 0.000 claims description 5
• 101001047640 Homo sapiens Linker for activation of T-cells family member 1 Proteins 0.000 claims description 5
• 101001109503 Homo sapiens NKG2-C type II integral membrane protein Proteins 0.000 claims description 5
• 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims description 5
• 101000589305 Homo sapiens Natural cytotoxicity triggering receptor 2 Proteins 0.000 claims description 5
• 101000873418 Homo sapiens P-selectin glycoprotein ligand 1 Proteins 0.000 claims description 5
• 101000692259 Homo sapiens Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Proteins 0.000 claims description 5
• 101000914496 Homo sapiens T-cell antigen CD7 Proteins 0.000 claims description 5
• 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 claims description 5
• 101000795169 Homo sapiens Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 claims description 5
• 101000679857 Homo sapiens Tumor necrosis factor receptor superfamily member 3 Proteins 0.000 claims description 5
• 108010073816 IgE Receptors Proteins 0.000 claims description 5
• 102000009438 IgE Receptors Human genes 0.000 claims description 5
• 108010041100 Integrin alpha6 Proteins 0.000 claims description 5
• 108010030465 Integrin alpha6beta1 Proteins 0.000 claims description 5
• 102100033016 Integrin beta-7 Human genes 0.000 claims description 5
• 102100024032 Linker for activation of T-cells family member 1 Human genes 0.000 claims description 5
• 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 5
• 108091008877 NK cell receptors Proteins 0.000 claims description 5
• 102100022683 NKG2-C type II integral membrane protein Human genes 0.000 claims description 5
• 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims description 5
• 108010004217 Natural Cytotoxicity Triggering Receptor 1 Proteins 0.000 claims description 5
• 108010004222 Natural Cytotoxicity Triggering Receptor 3 Proteins 0.000 claims description 5
• 102100032870 Natural cytotoxicity triggering receptor 1 Human genes 0.000 claims description 5
• 102100032851 Natural cytotoxicity triggering receptor 2 Human genes 0.000 claims description 5
• 102100032852 Natural cytotoxicity triggering receptor 3 Human genes 0.000 claims description 5
• 101710141230 Natural killer cell receptor 2B4 Proteins 0.000 claims description 5
• 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 claims description 5
• 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 5
• 102100026066 Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Human genes 0.000 claims description 5
• 102000008115 Signaling Lymphocytic Activation Molecule Family Member 1 Human genes 0.000 claims description 5
• 102100027208 T-cell antigen CD7 Human genes 0.000 claims description 5
• 102100035268 T-cell surface protein tactile Human genes 0.000 claims description 5
• 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 claims description 5
• 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 claims description 5
• 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 claims description 5
• 102100022156 Tumor necrosis factor receptor superfamily member 3 Human genes 0.000 claims description 5
• 108010072917 class-I restricted T cell-associated molecule Proteins 0.000 claims description 5
• 102000003675 cytokine receptors Human genes 0.000 claims description 5
• 108010057085 cytokine receptors Proteins 0.000 claims description 5
• 210000004443 dendritic cell Anatomy 0.000 claims description 5
• 229960005167 everolimus Drugs 0.000 claims description 5
• 201000005202 lung cancer Diseases 0.000 claims description 5
• 208000020816 lung neoplasm Diseases 0.000 claims description 5
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 5
• 201000002528 pancreatic cancer Diseases 0.000 claims description 5
• 208000008443 pancreatic carcinoma Diseases 0.000 claims description 5
• 230000019491 signal transduction Effects 0.000 claims description 5
• 208000023761 AL amyloidosis Diseases 0.000 claims description 4
• 108010062802 CD66 antigens Proteins 0.000 claims description 4
• 239000012275 CTLA-4 inhibitor Substances 0.000 claims description 4
• 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 claims description 4
• 102000004127 Cytokines Human genes 0.000 claims description 4
• 108090000695 Cytokines Proteins 0.000 claims description 4
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 claims description 4
• 101000900690 Homo sapiens GRB2-related adapter protein 2 Proteins 0.000 claims description 4
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 claims description 4
• 101000917858 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-A Proteins 0.000 claims description 4
• 101000917839 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor III-B Proteins 0.000 claims description 4
• 101001090688 Homo sapiens Lymphocyte cytosolic protein 2 Proteins 0.000 claims description 4
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 4
• 101000702132 Homo sapiens Protein spinster homolog 1 Proteins 0.000 claims description 4
• 206010020631 Hypergammaglobulinaemia benign monoclonal Diseases 0.000 claims description 4
• 108010065805 Interleukin-12 Proteins 0.000 claims description 4
• 102000013462 Interleukin-12 Human genes 0.000 claims description 4
• 102100034709 Lymphocyte cytosolic protein 2 Human genes 0.000 claims description 4
• 101100236305 Mus musculus Ly9 gene Proteins 0.000 claims description 4
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 4
• 208000012868 Overgrowth Diseases 0.000 claims description 4
• 239000012270 PD-1 inhibitor Substances 0.000 claims description 4
• 239000012668 PD-1-inhibitor Substances 0.000 claims description 4
• 239000012271 PD-L1 inhibitor Substances 0.000 claims description 4
• 208000006994 Precancerous Conditions Diseases 0.000 claims description 4
• 208000007541 Preleukemia Diseases 0.000 claims description 4
• 208000004346 Smoldering Multiple Myeloma Diseases 0.000 claims description 4
• 101001038499 Yarrowia lipolytica (strain CLIB 122 / E 150) Lysine acetyltransferase Proteins 0.000 claims description 4
• 230000000735 allogeneic effect Effects 0.000 claims description 4
• 208000035269 cancer or benign tumor Diseases 0.000 claims description 4
• 201000006569 extramedullary plasmacytoma Diseases 0.000 claims description 4
• 229940117681 interleukin-12 Drugs 0.000 claims description 4
• 230000003211 malignant effect Effects 0.000 claims description 4
• 208000010658 metastatic prostate carcinoma Diseases 0.000 claims description 4
• 201000005328 monoclonal gammopathy of uncertain significance Diseases 0.000 claims description 4
• 229940121655 pd-1 inhibitor Drugs 0.000 claims description 4
• 229940121656 pd-l1 inhibitor Drugs 0.000 claims description 4
• 230000001177 retroviral effect Effects 0.000 claims description 4
• 208000011580 syndromic disease Diseases 0.000 claims description 4
• 230000009885 systemic effect Effects 0.000 claims description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 3
• 206010000830 Acute leukaemia Diseases 0.000 claims description 3
• 208000004736 B-Cell Leukemia Diseases 0.000 claims description 3
• 208000036170 B-Cell Marginal Zone Lymphoma Diseases 0.000 claims description 3
• 208000025324 B-cell acute lymphoblastic leukemia Diseases 0.000 claims description 3
• 102100037904 CD9 antigen Human genes 0.000 claims description 3
• 101000585551 Equus caballus Pregnancy-associated glycoprotein Proteins 0.000 claims description 3
• 206010061850 Extranodal marginal zone B-cell lymphoma (MALT type) Diseases 0.000 claims description 3
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 3
• 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims description 3
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 claims description 3
• 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims description 3
• 101001124867 Homo sapiens Peroxiredoxin-1 Proteins 0.000 claims description 3
• 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 3
• 208000031671 Large B-Cell Diffuse Lymphoma Diseases 0.000 claims description 3
• 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims description 3
• 201000003791 MALT lymphoma Diseases 0.000 claims description 3
• 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims description 3
• 206010060880 Monoclonal gammopathy Diseases 0.000 claims description 3
• 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 3
• 208000029052 T-cell acute lymphoblastic leukemia Diseases 0.000 claims description 3
• 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims description 3
• 230000003013 cytotoxicity Effects 0.000 claims description 3
• 231100000135 cytotoxicity Toxicity 0.000 claims description 3
• 206010012818 diffuse large B-cell lymphoma Diseases 0.000 claims description 3
• 201000009277 hairy cell leukemia Diseases 0.000 claims description 3
• 239000007787 solid Substances 0.000 claims description 3
• 229940125565 BMS-986016 Drugs 0.000 claims description 2
• 101000738354 Homo sapiens CD9 antigen Proteins 0.000 claims description 2
• 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims description 2
• 229940125563 LAG3 inhibitor Drugs 0.000 claims description 2
• 208000030289 Lymphoproliferative disease Diseases 0.000 claims description 2
• 206010028570 Myelopathy Diseases 0.000 claims description 2
• 229940125566 REGN3767 Drugs 0.000 claims description 2
• 229940125567 TSR-033 Drugs 0.000 claims description 2
• 230000005809 anti-tumor immunity Effects 0.000 claims description 2
• 229960003852 atezolizumab Drugs 0.000 claims description 2
• 229950002916 avelumab Drugs 0.000 claims description 2
• 229950009791 durvalumab Drugs 0.000 claims description 2
• 229940124981 favezelimab Drugs 0.000 claims description 2
• 229940121569 ieramilimab Drugs 0.000 claims description 2
• 229960005386 ipilimumab Drugs 0.000 claims description 2
• 201000001268 lymphoproliferative syndrome Diseases 0.000 claims description 2
• 201000007924 marginal zone B-cell lymphoma Diseases 0.000 claims description 2
• 208000021937 marginal zone lymphoma Diseases 0.000 claims description 2
• 229960003301 nivolumab Drugs 0.000 claims description 2
• 229960002621 pembrolizumab Drugs 0.000 claims description 2
• 229950007213 spartalizumab Drugs 0.000 claims description 2
• 230000002463 transducing effect Effects 0.000 claims description 2
• 229950007217 tremelimumab Drugs 0.000 claims description 2
• 241000701161 unidentified adenovirus Species 0.000 claims description 2
• BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims 14
• 239000008177 pharmaceutical agent Substances 0.000 claims 2
• 102100028976 HLA class I histocompatibility antigen, B alpha chain Human genes 0.000 claims 1
• 101000934346 Homo sapiens T-cell surface antigen CD2 Proteins 0.000 claims 1
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 claims 1
• 102100029185 Low affinity immunoglobulin gamma Fc region receptor III-B Human genes 0.000 claims 1
• 102100021462 Natural killer cells antigen CD94 Human genes 0.000 claims 1
• 102100025237 T-cell surface antigen CD2 Human genes 0.000 claims 1
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 claims 1
• 201000005787 hematologic cancer Diseases 0.000 claims 1
• 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 1
• 210000003720 plasmablast Anatomy 0.000 claims 1
• 238000006467 substitution reaction Methods 0.000 description 456
• 230000004048 modification Effects 0.000 description 227
• 238000012986 modification Methods 0.000 description 227
• 108091007433 antigens Proteins 0.000 description 182
• 102000036639 antigens Human genes 0.000 description 182
• 239000000427 antigen Substances 0.000 description 177
• 235000018102 proteins Nutrition 0.000 description 43
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 38
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 37
• 108060003951 Immunoglobulin Proteins 0.000 description 36
• 235000001014 amino acid Nutrition 0.000 description 36
• 102000018358 immunoglobulin Human genes 0.000 description 36
• 229940024606 amino acid Drugs 0.000 description 34
• 102100040678 Programmed cell death protein 1 Human genes 0.000 description 33
• 101710089372 Programmed cell death protein 1 Proteins 0.000 description 33
• 239000002773 nucleotide Substances 0.000 description 28
• 125000003729 nucleotide group Chemical group 0.000 description 28
• 230000003834 intracellular effect Effects 0.000 description 27
• 230000000694 effects Effects 0.000 description 26
• 238000006471 dimerization reaction Methods 0.000 description 25
• 230000006870 function Effects 0.000 description 24
• 108020004999 messenger RNA Proteins 0.000 description 24
• 230000001086 cytosolic effect Effects 0.000 description 22
• 239000003795 chemical substances by application Substances 0.000 description 21
• 239000012642 immune effector Substances 0.000 description 20
• 229940121354 immunomodulator Drugs 0.000 description 20
• 230000002401 inhibitory effect Effects 0.000 description 20
• 108010027179 Tacrolimus Binding Proteins Proteins 0.000 description 19
• 102000018679 Tacrolimus Binding Proteins Human genes 0.000 description 19
• 230000004044 response Effects 0.000 description 18
• 229920002477 rna polymer Polymers 0.000 description 16
• 102000053602 DNA Human genes 0.000 description 15
• 238000001994 activation Methods 0.000 description 15
• 102000040430 polynucleotide Human genes 0.000 description 15
• 108091033319 polynucleotide Proteins 0.000 description 15
• 239000002157 polynucleotide Substances 0.000 description 15
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 14
• OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 14
• 102000005962 receptors Human genes 0.000 description 14
• 108020003175 receptors Proteins 0.000 description 14
• 125000000539 amino acid group Chemical group 0.000 description 13
• 239000000203 mixture Substances 0.000 description 13
• 230000035772 mutation Effects 0.000 description 13
• 230000004936 stimulating effect Effects 0.000 description 13
• 102100035932 Cocaine- and amphetamine-regulated transcript protein Human genes 0.000 description 12
• 101000715592 Homo sapiens Cocaine- and amphetamine-regulated transcript protein Proteins 0.000 description 12
• 102000010648 Natural Killer Cell Receptors Human genes 0.000 description 11
• 210000003719 b-lymphocyte Anatomy 0.000 description 11
• 239000000463 material Substances 0.000 description 11
• 239000000047 product Substances 0.000 description 11
• 125000006850 spacer group Chemical group 0.000 description 11
• 108010087819 Fc receptors Proteins 0.000 description 10
• 102000009109 Fc receptors Human genes 0.000 description 10
• 102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 description 10
• 230000007423 decrease Effects 0.000 description 10
• 108020001507 fusion proteins Proteins 0.000 description 10
• 102000037865 fusion proteins Human genes 0.000 description 10
• 230000001965 increasing effect Effects 0.000 description 10
• 230000035897 transcription Effects 0.000 description 10
• 238000013518 transcription Methods 0.000 description 10
• 108010003723 Single-Domain Antibodies Proteins 0.000 description 9
• 238000012217 deletion Methods 0.000 description 9
• 230000037430 deletion Effects 0.000 description 9
• 239000012636 effector Substances 0.000 description 9
• 230000028993 immune response Effects 0.000 description 9
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 8
• 108010074708 B7-H1 Antigen Proteins 0.000 description 8
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 8
• 108091054437 MHC class I family Proteins 0.000 description 8
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 8
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 description 8
• 241000700605 Viruses Species 0.000 description 8
• 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 8
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 8
• 208000024891 symptom Diseases 0.000 description 8
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 7
• 239000002126 C01EB10 - Adenosine Substances 0.000 description 7
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 7
• 108010043610 KIR Receptors Proteins 0.000 description 7
• 102000002698 KIR Receptors Human genes 0.000 description 7
• 108010077854 Natural Killer Cell Receptors Proteins 0.000 description 7
• 229960005305 adenosine Drugs 0.000 description 7
• 230000003993 interaction Effects 0.000 description 7
• 230000009467 reduction Effects 0.000 description 7
• 230000001105 regulatory effect Effects 0.000 description 7
• 241000894007 species Species 0.000 description 7
• 230000004083 survival effect Effects 0.000 description 7
• 238000013519 translation Methods 0.000 description 7
• 210000004881 tumor cell Anatomy 0.000 description 7
• 238000011144 upstream manufacturing Methods 0.000 description 7
• 241000282832 Camelidae Species 0.000 description 6
• 241000251730 Chondrichthyes Species 0.000 description 6
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 description 6
• 102000043129 MHC class I family Human genes 0.000 description 6
• 101100407308 Mus musculus Pdcd1lg2 gene Proteins 0.000 description 6
• 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 description 6
• 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 description 6
• 210000004369 blood Anatomy 0.000 description 6
• 239000008280 blood Substances 0.000 description 6
• 230000000875 corresponding effect Effects 0.000 description 6
• 238000003780 insertion Methods 0.000 description 6
• 230000037431 insertion Effects 0.000 description 6
• 102000006495 integrins Human genes 0.000 description 6
• 108010044426 integrins Proteins 0.000 description 6
• 208000032839 leukemia Diseases 0.000 description 6
• 210000001519 tissue Anatomy 0.000 description 6
• 239000013603 viral vector Substances 0.000 description 6
• 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 description 5
• 101150051188 Adora2a gene Proteins 0.000 description 5
• 102100031351 Galectin-9 Human genes 0.000 description 5
• 101100229077 Gallus gallus GAL9 gene Proteins 0.000 description 5
• 239000004471 Glycine Substances 0.000 description 5
• 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 description 5
• 101001138062 Homo sapiens Leukocyte-associated immunoglobulin-like receptor 1 Proteins 0.000 description 5
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 description 5
• 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 description 5
• 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 description 5
• 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 description 5
• 102000017578 LAG3 Human genes 0.000 description 5
• 102100020943 Leukocyte-associated immunoglobulin-like receptor 1 Human genes 0.000 description 5
• 102000043131 MHC class II family Human genes 0.000 description 5
• 108091054438 MHC class II family Proteins 0.000 description 5
• 102100023085 Serine/threonine-protein kinase mTOR Human genes 0.000 description 5
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 description 5
• 108010079206 V-Set Domain-Containing T-Cell Activation Inhibitor 1 Proteins 0.000 description 5
• 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 description 5
• 230000000259 anti-tumor effect Effects 0.000 description 5
• 230000015572 biosynthetic process Effects 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 150000001875 compounds Chemical class 0.000 description 5
• 239000000539 dimer Substances 0.000 description 5
• 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 5
• IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 5
• 230000002489 hematologic effect Effects 0.000 description 5
• 230000006872 improvement Effects 0.000 description 5
• 210000003071 memory t lymphocyte Anatomy 0.000 description 5
• 230000036961 partial effect Effects 0.000 description 5
• 230000008488 polyadenylation Effects 0.000 description 5
• 230000035755 proliferation Effects 0.000 description 5
• 239000000523 sample Substances 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 230000008685 targeting Effects 0.000 description 5
• 238000002560 therapeutic procedure Methods 0.000 description 5
• 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 4
• 102000006306 Antigen Receptors Human genes 0.000 description 4
• 108010083359 Antigen Receptors Proteins 0.000 description 4
• 208000023275 Autoimmune disease Diseases 0.000 description 4
• 102000050627 Glucocorticoid-Induced TNFR-Related Human genes 0.000 description 4
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 4
• 208000017604 Hodgkin disease Diseases 0.000 description 4
• 208000021519 Hodgkin lymphoma Diseases 0.000 description 4
• 208000010747 Hodgkins lymphoma Diseases 0.000 description 4
• 101000801255 Homo sapiens Tumor necrosis factor receptor superfamily member 17 Proteins 0.000 description 4
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 4
• 241001465754 Metazoa Species 0.000 description 4
• 241000699666 Mus <mouse, genus> Species 0.000 description 4
• 102000015636 Oligopeptides Human genes 0.000 description 4
• 108010038807 Oligopeptides Proteins 0.000 description 4
• 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 4
• 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 4
• 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 4
• 101710187882 Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 4
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 4
• MXKCYTKUIDTFLY-ZNNSSXPHSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc-(1->3)-D-Galp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](NC(C)=O)[C@H](O[C@H]3[C@H]([C@@H](CO)OC(O)[C@@H]3O)O)O[C@@H]2CO)O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)O[C@H](CO)[C@H](O)[C@@H]1O MXKCYTKUIDTFLY-ZNNSSXPHSA-N 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• 239000002299 complementary DNA Substances 0.000 description 4
• 230000001419 dependent effect Effects 0.000 description 4
• 229940079593 drug Drugs 0.000 description 4
• 238000005734 heterodimerization reaction Methods 0.000 description 4
• 229940072221 immunoglobulins Drugs 0.000 description 4
• 230000002434 immunopotentiative effect Effects 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• 229940043355 kinase inhibitor Drugs 0.000 description 4
• 210000004698 lymphocyte Anatomy 0.000 description 4
• 239000003757 phosphotransferase inhibitor Substances 0.000 description 4
• 229920000642 polymer Polymers 0.000 description 4
• 230000008569 process Effects 0.000 description 4
• 208000016691 refractory malignant neoplasm Diseases 0.000 description 4
• 230000000638 stimulation Effects 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 239000004474 valine Substances 0.000 description 4
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
• 101710178046 Chorismate synthase 1 Proteins 0.000 description 3
• 108020004705 Codon Proteins 0.000 description 3
• 101710152695 Cysteine synthase 1 Proteins 0.000 description 3
• BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 3
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 3
• 241000235789 Hyperoartia Species 0.000 description 3
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 3
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
• 102100033467 L-selectin Human genes 0.000 description 3
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 102100029193 Low affinity immunoglobulin gamma Fc region receptor III-A Human genes 0.000 description 3
• 108060001084 Luciferase Proteins 0.000 description 3
• 239000005089 Luciferase Substances 0.000 description 3
• 102000048850 Neoplasm Genes Human genes 0.000 description 3
• 108700019961 Neoplasm Genes Proteins 0.000 description 3
• 108091036407 Polyadenylation Proteins 0.000 description 3
• 102100032831 Protein ITPRID2 Human genes 0.000 description 3
• 108020004511 Recombinant DNA Proteins 0.000 description 3
• 206010070308 Refractory cancer Diseases 0.000 description 3
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
• 108090001012 Transforming Growth Factor beta Proteins 0.000 description 3
• 102000004887 Transforming Growth Factor beta Human genes 0.000 description 3
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
• 102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 description 3
• 238000007792 addition Methods 0.000 description 3
• 230000001093 anti-cancer Effects 0.000 description 3
• 230000003302 anti-idiotype Effects 0.000 description 3
• 238000002617 apheresis Methods 0.000 description 3
• 238000003556 assay Methods 0.000 description 3
• 230000005540 biological transmission Effects 0.000 description 3
• 210000004899 c-terminal region Anatomy 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 230000004663 cell proliferation Effects 0.000 description 3
• 230000001413 cellular effect Effects 0.000 description 3
• 230000000295 complement effect Effects 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 239000013604 expression vector Substances 0.000 description 3
• 230000004727 humoral immunity Effects 0.000 description 3
• 230000003463 hyperproliferative effect Effects 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 238000004020 luminiscence type Methods 0.000 description 3
• 229920002521 macromolecule Polymers 0.000 description 3
• 239000003550 marker Substances 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 230000002018 overexpression Effects 0.000 description 3
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
• 239000002243 precursor Substances 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 229960001153 serine Drugs 0.000 description 3
• 150000003384 small molecules Chemical group 0.000 description 3
• 238000003786 synthesis reaction Methods 0.000 description 3
• 230000009258 tissue cross reactivity Effects 0.000 description 3
• 229960004799 tryptophan Drugs 0.000 description 3
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
• 241001430294 unidentified retrovirus Species 0.000 description 3
• NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 2
• 108010013238 70-kDa Ribosomal Protein S6 Kinases Proteins 0.000 description 2
• 241000251468 Actinopterygii Species 0.000 description 2
• 229930024421 Adenine Natural products 0.000 description 2
• 235000002198 Annona diversifolia Nutrition 0.000 description 2
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 2
• 108091012583 BCL2 Proteins 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000026310 Breast neoplasm Diseases 0.000 description 2
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 2
• 108010021064 CTLA-4 Antigen Proteins 0.000 description 2
• 101100228196 Caenorhabditis elegans gly-4 gene Proteins 0.000 description 2
• 102000014914 Carrier Proteins Human genes 0.000 description 2
• 102100026550 Caspase-9 Human genes 0.000 description 2
• 108090000566 Caspase-9 Proteins 0.000 description 2
• 206010008342 Cervix carcinoma Diseases 0.000 description 2
• 108091026890 Coding region Proteins 0.000 description 2
• 108091033380 Coding strand Proteins 0.000 description 2
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
• 241000702421 Dependoparvovirus Species 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 102100037362 Fibronectin Human genes 0.000 description 2
• 108010067306 Fibronectins Proteins 0.000 description 2
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 2
• 241000282412 Homo Species 0.000 description 2
• 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 2
• 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 description 2
• 101000945339 Homo sapiens Killer cell immunoglobulin-like receptor 2DS2 Proteins 0.000 description 2
• 101000971533 Homo sapiens Killer cell lectin-like receptor subfamily G member 1 Proteins 0.000 description 2
• 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 2
• 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 2
• 101000884271 Homo sapiens Signal transducer CD24 Proteins 0.000 description 2
• 241000725303 Human immunodeficiency virus Species 0.000 description 2
• 206010062016 Immunosuppression Diseases 0.000 description 2
• 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 description 2
• 108091092195 Intron Proteins 0.000 description 2
• 208000008839 Kidney Neoplasms Diseases 0.000 description 2
• 102100033630 Killer cell immunoglobulin-like receptor 2DS2 Human genes 0.000 description 2
• 102100021457 Killer cell lectin-like receptor subfamily G member 1 Human genes 0.000 description 2
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
• 241000282838 Lama Species 0.000 description 2
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 2
• 206010027476 Metastases Diseases 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 241000283973 Oryctolagus cuniculus Species 0.000 description 2
• 206010033128 Ovarian cancer Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 208000009052 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
• 108091034057 RNA (poly(A)) Proteins 0.000 description 2
• 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 description 2
• 206010038389 Renal cancer Diseases 0.000 description 2
• 208000007660 Residual Neoplasm Diseases 0.000 description 2
• 102100038081 Signal transducer CD24 Human genes 0.000 description 2
• 230000006044 T cell activation Effects 0.000 description 2
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
• 239000004473 Threonine Substances 0.000 description 2
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
• 102100040247 Tumor necrosis factor Human genes 0.000 description 2
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
• GQLCLPLEEOUJQC-ZTQDTCGGSA-N [(1r)-3-(3,4-dimethoxyphenyl)-1-[3-[2-[2-[[2-[3-[(1r)-3-(3,4-dimethoxyphenyl)-1-[(2s)-1-[(2s)-2-(3,4,5-trimethoxyphenyl)butanoyl]piperidine-2-carbonyl]oxypropyl]phenoxy]acetyl]amino]ethylamino]-2-oxoethoxy]phenyl]propyl] (2s)-1-[(2s)-2-(3,4,5-trimethoxyph Chemical compound C([C@@H](OC(=O)[C@@H]1CCCCN1C(=O)[C@@H](CC)C=1C=C(OC)C(OC)=C(OC)C=1)C=1C=C(OCC(=O)NCCNC(=O)COC=2C=C(C=CC=2)[C@@H](CCC=2C=C(OC)C(OC)=CC=2)OC(=O)[C@H]2N(CCCC2)C(=O)[C@@H](CC)C=2C=C(OC)C(OC)=C(OC)C=2)C=CC=1)CC1=CC=C(OC)C(OC)=C1 GQLCLPLEEOUJQC-ZTQDTCGGSA-N 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 230000000996 additive effect Effects 0.000 description 2
• 235000004279 alanine Nutrition 0.000 description 2
• 230000001588 bifunctional effect Effects 0.000 description 2
• 108091008324 binding proteins Proteins 0.000 description 2
• 239000012472 biological sample Substances 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 150000001720 carbohydrates Chemical class 0.000 description 2
• 235000014633 carbohydrates Nutrition 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 201000010881 cervical cancer Diseases 0.000 description 2
• 229960005395 cetuximab Drugs 0.000 description 2
• 238000010382 chemical cross-linking Methods 0.000 description 2
• 239000003153 chemical reaction reagent Substances 0.000 description 2
• 230000001276 controlling effect Effects 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 238000004132 cross linking Methods 0.000 description 2
• 230000016396 cytokine production Effects 0.000 description 2
• 230000001461 cytolytic effect Effects 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 230000018109 developmental process Effects 0.000 description 2
• 210000003162 effector t lymphocyte Anatomy 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 238000000684 flow cytometry Methods 0.000 description 2
• 230000005714 functional activity Effects 0.000 description 2
• 238000001476 gene delivery Methods 0.000 description 2
• 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 238000010362 genome editing Methods 0.000 description 2
• 230000012010 growth Effects 0.000 description 2
• 239000000833 heterodimer Substances 0.000 description 2
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
• 210000002865 immune cell Anatomy 0.000 description 2
• 229940127121 immunoconjugate Drugs 0.000 description 2
• 230000001506 immunosuppresive effect Effects 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 229960000310 isoleucine Drugs 0.000 description 2
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
• 201000010982 kidney cancer Diseases 0.000 description 2
• 229960003136 leucine Drugs 0.000 description 2
• 150000002632 lipids Chemical class 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 201000007270 liver cancer Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 206010025135 lupus erythematosus Diseases 0.000 description 2
• 230000001404 mediated effect Effects 0.000 description 2
• 210000004985 myeloid-derived suppressor cell Anatomy 0.000 description 2
• 230000001575 pathological effect Effects 0.000 description 2
• 230000007170 pathology Effects 0.000 description 2
• 230000002688 persistence Effects 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• 230000002265 prevention Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 230000028327 secretion Effects 0.000 description 2
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 239000000126 substance Substances 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 230000001225 therapeutic effect Effects 0.000 description 2
• 229960002898 threonine Drugs 0.000 description 2
• 102000035160 transmembrane proteins Human genes 0.000 description 2
• 108091005703 transmembrane proteins Proteins 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 239000000439 tumor marker Substances 0.000 description 2
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 2
• HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical group NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 1
• VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
• FSPQCTGGIANIJZ-UHFFFAOYSA-N 2-[[(3,4-dimethoxyphenyl)-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide Chemical compound C1=C(OC)C(OC)=CC=C1C(=O)NC1=C(C(N)=O)C(CCCC2)=C2S1 FSPQCTGGIANIJZ-UHFFFAOYSA-N 0.000 description 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
• 208000003200 Adenoma Diseases 0.000 description 1
• 206010001233 Adenoma benign Diseases 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 102100035248 Alpha-(1,3)-fucosyltransferase 4 Human genes 0.000 description 1
• 241000252073 Anguilliformes Species 0.000 description 1
• 108020005544 Antisense RNA Proteins 0.000 description 1
• 239000004475 Arginine Substances 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 208000025321 B-lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 102100032412 Basigin Human genes 0.000 description 1
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
• 206010005003 Bladder cancer Diseases 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
• 102100026094 C-type lectin domain family 12 member A Human genes 0.000 description 1
• 101710188619 C-type lectin domain family 12 member A Proteins 0.000 description 1
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
• 108010029697 CD40 Ligand Proteins 0.000 description 1
• 102100032912 CD44 antigen Human genes 0.000 description 1
• 102100036008 CD48 antigen Human genes 0.000 description 1
• 108010065524 CD52 Antigen Proteins 0.000 description 1
• 241000282836 Camelus dromedarius Species 0.000 description 1
• 241000283707 Capra Species 0.000 description 1
• 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 1
• 102000011727 Caspases Human genes 0.000 description 1
• 108010076667 Caspases Proteins 0.000 description 1
• 102000000844 Cell Surface Receptors Human genes 0.000 description 1
• 108010001857 Cell Surface Receptors Proteins 0.000 description 1
• 206010057248 Cell death Diseases 0.000 description 1
• 108091007741 Chimeric antigen receptor T cells Proteins 0.000 description 1
• 108091062157 Cis-regulatory element Proteins 0.000 description 1
• 206010009900 Colitis ulcerative Diseases 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• 206010058314 Dysplasia Diseases 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 241000710188 Encephalomyocarditis virus Species 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 1
• 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 1
• 108060002716 Exonuclease Proteins 0.000 description 1
• 108010054218 Factor VIII Proteins 0.000 description 1
• 102000001690 Factor VIII Human genes 0.000 description 1
• 102000002090 Fibronectin type III Human genes 0.000 description 1
• 108050009401 Fibronectin type III Proteins 0.000 description 1
• 108090000331 Firefly luciferases Proteins 0.000 description 1
• 102000010449 Folate receptor beta Human genes 0.000 description 1
• 108050001930 Folate receptor beta Proteins 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
• 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 description 1
• 102000025850 HLA-A2 Antigen Human genes 0.000 description 1
• 108010074032 HLA-A2 Antigen Proteins 0.000 description 1
• 102000006354 HLA-DR Antigens Human genes 0.000 description 1
• 108010058597 HLA-DR Antigens Proteins 0.000 description 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
• 101001022185 Homo sapiens Alpha-(1,3)-fucosyltransferase 4 Proteins 0.000 description 1
• 101000798441 Homo sapiens Basigin Proteins 0.000 description 1
• 101100005238 Homo sapiens CARTPT gene Proteins 0.000 description 1
• 101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
• 101000716130 Homo sapiens CD48 antigen Proteins 0.000 description 1
• 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
• 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 1
• 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 description 1
• 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 description 1
• 101001078143 Homo sapiens Integrin alpha-IIb Proteins 0.000 description 1
• 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 description 1
• 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 1
• 101000960936 Homo sapiens Interleukin-5 receptor subunit alpha Proteins 0.000 description 1
• 101001027081 Homo sapiens Killer cell immunoglobulin-like receptor 2DL1 Proteins 0.000 description 1
• 101000945371 Homo sapiens Killer cell immunoglobulin-like receptor 2DL2 Proteins 0.000 description 1
• 101000945331 Homo sapiens Killer cell immunoglobulin-like receptor 2DL4 Proteins 0.000 description 1
• 101000945337 Homo sapiens Killer cell immunoglobulin-like receptor 2DL5A Proteins 0.000 description 1
• 101000945335 Homo sapiens Killer cell immunoglobulin-like receptor 2DL5B Proteins 0.000 description 1
• 101000945340 Homo sapiens Killer cell immunoglobulin-like receptor 2DS1 Proteins 0.000 description 1
• 101000945343 Homo sapiens Killer cell immunoglobulin-like receptor 2DS3 Proteins 0.000 description 1
• 101000945342 Homo sapiens Killer cell immunoglobulin-like receptor 2DS4 Proteins 0.000 description 1
• 101000945351 Homo sapiens Killer cell immunoglobulin-like receptor 3DL1 Proteins 0.000 description 1
• 101000945490 Homo sapiens Killer cell immunoglobulin-like receptor 3DL2 Proteins 0.000 description 1
• 101000945493 Homo sapiens Killer cell immunoglobulin-like receptor 3DL3 Proteins 0.000 description 1
• 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 description 1
• 101001133056 Homo sapiens Mucin-1 Proteins 0.000 description 1
• 101000623901 Homo sapiens Mucin-16 Proteins 0.000 description 1
• 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 description 1
• 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 description 1
• 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 1
• 101000633792 Homo sapiens SLAM family member 9 Proteins 0.000 description 1
• 101001050288 Homo sapiens Transcription factor Jun Proteins 0.000 description 1
• 101000904724 Homo sapiens Transmembrane glycoprotein NMB Proteins 0.000 description 1
• 101000801433 Homo sapiens Trophoblast glycoprotein Proteins 0.000 description 1
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
• 101000610605 Homo sapiens Tumor necrosis factor receptor superfamily member 10A Proteins 0.000 description 1
• 108090000144 Human Proteins Proteins 0.000 description 1
• 102000003839 Human Proteins Human genes 0.000 description 1
• 206010020751 Hypersensitivity Diseases 0.000 description 1
• 102000009786 Immunoglobulin Constant Regions Human genes 0.000 description 1
• 108010009817 Immunoglobulin Constant Regions Proteins 0.000 description 1
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
• 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 description 1
• 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
• 102100025306 Integrin alpha-IIb Human genes 0.000 description 1
• 102100022337 Integrin alpha-V Human genes 0.000 description 1
• 102000015271 Intercellular Adhesion Molecule-1 Human genes 0.000 description 1
• 102000001617 Interferon Receptors Human genes 0.000 description 1
• 108010054267 Interferon Receptors Proteins 0.000 description 1
• 102100037850 Interferon gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 102100039881 Interleukin-5 receptor subunit alpha Human genes 0.000 description 1
• 108010038501 Interleukin-6 Receptors Proteins 0.000 description 1
• 102000010781 Interleukin-6 Receptors Human genes 0.000 description 1
• 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 1
• 102100037363 Killer cell immunoglobulin-like receptor 2DL1 Human genes 0.000 description 1
• 102100033599 Killer cell immunoglobulin-like receptor 2DL2 Human genes 0.000 description 1
• 102100033633 Killer cell immunoglobulin-like receptor 2DL4 Human genes 0.000 description 1
• 102100033629 Killer cell immunoglobulin-like receptor 2DL5A Human genes 0.000 description 1
• 102100033628 Killer cell immunoglobulin-like receptor 2DL5B Human genes 0.000 description 1
• 102100033631 Killer cell immunoglobulin-like receptor 2DS1 Human genes 0.000 description 1
• 102100033625 Killer cell immunoglobulin-like receptor 2DS3 Human genes 0.000 description 1
• 102100033624 Killer cell immunoglobulin-like receptor 2DS4 Human genes 0.000 description 1
• 102100033627 Killer cell immunoglobulin-like receptor 3DL1 Human genes 0.000 description 1
• 102100034840 Killer cell immunoglobulin-like receptor 3DL2 Human genes 0.000 description 1
• 102100034834 Killer cell immunoglobulin-like receptor 3DL3 Human genes 0.000 description 1
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
• 241000282852 Lama guanicoe Species 0.000 description 1
• 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 239000004472 Lysine Substances 0.000 description 1
• 241000124008 Mammalia Species 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 206010027480 Metastatic malignant melanoma Diseases 0.000 description 1
• 102100034256 Mucin-1 Human genes 0.000 description 1
• 102100023123 Mucin-16 Human genes 0.000 description 1
• 101100181099 Mus musculus Klra1 gene Proteins 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• 108090000028 Neprilysin Proteins 0.000 description 1
• 102000003729 Neprilysin Human genes 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 208000008589 Obesity Diseases 0.000 description 1
• 108700026244 Open Reading Frames Proteins 0.000 description 1
• 108091008606 PDGF receptors Proteins 0.000 description 1
• 108091007960 PI3Ks Proteins 0.000 description 1
• 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 1
• 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 1
• 102100027913 Peptidyl-prolyl cis-trans isomerase FKBP1A Human genes 0.000 description 1
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 102000011653 Platelet-Derived Growth Factor Receptors Human genes 0.000 description 1
• 108010039918 Polylysine Proteins 0.000 description 1
• 102000015623 Polynucleotide Adenylyltransferase Human genes 0.000 description 1
• 108010024055 Polynucleotide adenylyltransferase Proteins 0.000 description 1
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
• 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
• 101800001295 Putative ATP-dependent helicase Proteins 0.000 description 1
• 101800001006 Putative helicase Proteins 0.000 description 1
• 108020005161 RNA Caps Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 101710151245 Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 description 1
• 235000004443 Ricinus communis Nutrition 0.000 description 1
• 102100029196 SLAM family member 9 Human genes 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 208000021386 Sjogren Syndrome Diseases 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 108010006877 Tacrolimus Binding Protein 1A Proteins 0.000 description 1
• 208000002474 Tinea Diseases 0.000 description 1
• 241000130764 Tinea Species 0.000 description 1
• 102100023132 Transcription factor Jun Human genes 0.000 description 1
• 108700019146 Transgenes Proteins 0.000 description 1
• 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 description 1
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
• 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 1
• 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 description 1
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 1
• 101710165434 Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 1
• 206010054094 Tumour necrosis Diseases 0.000 description 1
• 201000006704 Ulcerative Colitis Diseases 0.000 description 1
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 1
• 208000002495 Uterine Neoplasms Diseases 0.000 description 1
• 108091008605 VEGF receptors Proteins 0.000 description 1
• 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
• 241001416177 Vicugna pacos Species 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 241001193851 Zeta Species 0.000 description 1
• 230000002159 abnormal effect Effects 0.000 description 1
• 108091022873 acetoacetate decarboxylase Proteins 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 229960000643 adenine Drugs 0.000 description 1
• 208000009956 adenocarcinoma Diseases 0.000 description 1
• 150000003838 adenosines Chemical class 0.000 description 1
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
• 230000007815 allergy Effects 0.000 description 1
• 230000003281 allosteric effect Effects 0.000 description 1
• 206010002022 amyloidosis Diseases 0.000 description 1
• 229940049595 antibody-drug conjugate Drugs 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 230000006907 apoptotic process Effects 0.000 description 1
• 238000013459 approach Methods 0.000 description 1
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• 235000003704 aspartic acid Nutrition 0.000 description 1
• 208000006673 asthma Diseases 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
• OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
• 238000005842 biochemical reaction Methods 0.000 description 1
• 230000031018 biological processes and functions Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 229960000074 biopharmaceutical Drugs 0.000 description 1
• 230000001851 biosynthetic effect Effects 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• 239000010839 body fluid Substances 0.000 description 1
• 210000002798 bone marrow cell Anatomy 0.000 description 1
• 229940112129 campath Drugs 0.000 description 1
• 230000009702 cancer cell proliferation Effects 0.000 description 1
• 230000015556 catabolic process Effects 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 230000022534 cell killing Effects 0.000 description 1
• 230000011748 cell maturation Effects 0.000 description 1
• 230000005754 cellular signaling Effects 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 210000000349 chromosome Anatomy 0.000 description 1
• 208000024207 chronic leukemia Diseases 0.000 description 1
• 238000002983 circular dichroism Methods 0.000 description 1
• 238000003501 co-culture Methods 0.000 description 1
• 108700032673 cocaine- and amphetamine-regulated transcript Proteins 0.000 description 1
• 230000003750 conditioning effect Effects 0.000 description 1
• 108091008034 costimulatory receptors Proteins 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 230000003436 cytoskeletal effect Effects 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 238000006731 degradation reaction Methods 0.000 description 1
• 230000000779 depleting effect Effects 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• 230000003828 downregulation Effects 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 229940088598 enzyme Drugs 0.000 description 1
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
• 230000008029 eradication Effects 0.000 description 1
• 102000013165 exonuclease Human genes 0.000 description 1
• 229960000301 factor viii Drugs 0.000 description 1
• 102000006815 folate receptor Human genes 0.000 description 1
• 108020005243 folate receptor Proteins 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 238000002825 functional assay Methods 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 208000005017 glioblastoma Diseases 0.000 description 1
• 235000013922 glutamic acid Nutrition 0.000 description 1
• 239000004220 glutamic acid Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 229960002743 glutamine Drugs 0.000 description 1
• 229960002449 glycine Drugs 0.000 description 1
• 150000002333 glycines Chemical class 0.000 description 1
• 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
• 108010033706 glycylserine Proteins 0.000 description 1
• 230000009036 growth inhibition Effects 0.000 description 1
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 230000036541 health Effects 0.000 description 1
• 102000046935 human TNFRSF17 Human genes 0.000 description 1
• 125000001165 hydrophobic group Chemical group 0.000 description 1
• 230000008004 immune attack Effects 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 208000026278 immune system disease Diseases 0.000 description 1
• 230000036039 immunity Effects 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 229960003444 immunosuppressant agent Drugs 0.000 description 1
• 230000001861 immunosuppressant effect Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000006882 induction of apoptosis Effects 0.000 description 1
• 208000027866 inflammatory disease Diseases 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 229940090044 injection Drugs 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 210000004324 lymphatic system Anatomy 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 210000001806 memory b lymphocyte Anatomy 0.000 description 1
• 208000021039 metastatic melanoma Diseases 0.000 description 1
• 229930182817 methionine Natural products 0.000 description 1
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
• 238000002703 mutagenesis Methods 0.000 description 1
• 231100000350 mutagenesis Toxicity 0.000 description 1
• 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 235000020824 obesity Nutrition 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 210000001539 phagocyte Anatomy 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 208000007525 plasmablastic lymphoma Diseases 0.000 description 1
• 210000005134 plasmacytoid dendritic cell Anatomy 0.000 description 1
• 229920000656 polylysine Polymers 0.000 description 1
• 238000003752 polymerase chain reaction Methods 0.000 description 1
• 208000017426 precursor B-cell acute lymphoblastic leukemia Diseases 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 238000011321 prophylaxis Methods 0.000 description 1
• 230000005180 public health Effects 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 206010039073 rheumatoid arthritis Diseases 0.000 description 1
• 229950004008 rimiducid Drugs 0.000 description 1
• 229960004641 rituximab Drugs 0.000 description 1
• 102220191892 rs199825512 Human genes 0.000 description 1
• 102220058139 rs372082751 Human genes 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 230000008054 signal transmission Effects 0.000 description 1
• 230000007781 signaling event Effects 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 230000000087 stabilizing effect Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 238000011476 stem cell transplantation Methods 0.000 description 1
• 210000002536 stromal cell Anatomy 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
• 101150047061 tag-72 gene Proteins 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• 125000003396 thiol group Chemical group [H]S* 0.000 description 1
• 210000000115 thoracic cavity Anatomy 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 239000003053 toxin Substances 0.000 description 1
• 231100000765 toxin Toxicity 0.000 description 1
• 108700012359 toxins Proteins 0.000 description 1
• 230000005026 transcription initiation Effects 0.000 description 1
• 230000005030 transcription termination Effects 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 238000010361 transduction Methods 0.000 description 1
• 230000026683 transduction Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000010474 transient expression Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1
• 230000004222 uncontrolled growth Effects 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
• 229940045145 uridine Drugs 0.000 description 1
• 201000005112 urinary bladder cancer Diseases 0.000 description 1
• 206010046766 uterine cancer Diseases 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 230000003612 virological effect Effects 0.000 description 1